Two Sigma Advisers’s Cano Health, Inc. CANO Stock Holding History

Two Sigma Advisers’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-446	Closed	-$283K	–	2948
2022 Q1	$283K	Sell	446 -222	-33%	-$140K	﹤0.01%	2250
2021 Q4	$595K	Buy	+668	New	+$702K	﹤0.01%	1834

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Advisers's CANO Position: Q2 2022 in Review

Two Sigma Advisers sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 446 shares — an estimated $283K sold.

Two Sigma Advisers first reported a position in CANO in Q4 2021 and held it in 2 quarters. The position peaked at $595K in Q4 2021. 144 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

Two Sigma Advisers reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
Two Sigma Advisers sold 446 Cano Health, Inc. shares in Q2 2022, an estimated $283K.
Two Sigma Advisers first reported a position in Cano Health, Inc. in Q4 2021 and held it in 2 quarters.
Two Sigma Advisers's Cano Health, Inc. position peaked at $595K in Q4 2021.
144 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.